Sydney A. Kert

Partner

About

Areas of FocusCorporate Mergers and Acquisitions Corporate Venture Capital Emerging Growth and Venture Capital Equity Capital Markets Private Equity

Bar admissionsOntario, 2012

EXPERIENCE

Acted for Quipt Home Medical Corp. (NASDAQ: QIPT; TSX: QIPT) in connection with the filing of a base shelf prospectus ‎for up to $300 million of securities of the issuer.
Advised Dye & Durham on Canadian capital markets matters in connection with its private offering of US$555 million ‎aggregate principal amount senior secured notes due ‎‎2029 as part of its US$950 million refinancing transactions.
Nova Royalty on its arrangement transaction with Metalla Royalty & Streaming with debt and equity ‎‎financing for an aggregate transaction value of $260 million. ‎
PODA Holdings on its multiparty sale of intellectual property assets to Altria Group for US$100 million.
Adventus Mining on its arrangement transaction with Luminex Resources with concurrent equity financing ‎for an aggregate transaction value of $90 million.
Represented a syndicate of underwriters, co-led by PI Financial Corp. and CIBC Capital Markets, in connection with Paycore Minerals Inc.’s (TSX: CORE) $18.4 million bought deal public offering.
Represented Quipt Home Medical Corp. (NASDAQ:QIPT; TSXV:QIPT) in connection with its US$80 million acquisition of Great Elm Healthcare, LLC, a division of Great Elm Group, Inc. (NASDAQ:GEG).
Represented Ascend Wellness Holdings‎ (CSE: AAWH.U‎) in its US$92 million cross-border initial public offering.
Represented a syndicate of underwriters co-led by Canaccord Genuity Corp. and ATB Capital Markets Inc. in the $149.5 million bought deal public offering of common shares of Columbia Care Inc. (NEO: CCHW) (CSE: CCHW) (OTCQX: CCHWF) (FSE: 3LP).
Represented Protech Home Medical Corp. (TSXV:PTQ) in connection with its $31.8 million short form prospectus bought deal offering and concurrent private placement of units.
Advised Canadian independent bandwidth infrastructure provider Beanfield Technologies in its acquisition by Digital Colony Capital, Inc.
Represented Acreage Holdings, Inc. (CSE: ACRG.U) in its USD$3.4 billion arrangement with Canopy Growth.
Represented High Street Capital Partners, LLC in connection with its USD$314.2 million subscription receipt financing, reverse take-over of Applied Inventions Management Corp. and the listing of the resulting issuer, Acreage Holdings, Inc. (CSE: ACRG.U), on the Canadian Securities Exchange.
Represented a syndicate of agents, co-led by Canaccord Genuity Corp. and GMP Securities L.P. in connection with Maricann Group Inc.'s $37.4 million special warrant offering.
Represented a syndicate of dealers co-led by Cormark Securities and Canaccord Genuity in connection with Growforce Holdings' $38 million subscription receipt offering.
Represented Sarment Holding Limited (TSX-V:SAIS) in connection with its $19 million initial public offering and TSX Venture Exchange listing.
Represented Newstrike Brands Ltd. (TSXV:HIP) in connection with its $45 million bought deal offering of units.
Representing a syndicate of underwriters, led by Canaccord Genuity Corp., in connection with Aurora Cannabis Inc.’s (TSX: ACB) $230 million bought deal offering of convertible debentures.
Represented KES 7 Capital Inc. in connection with a US$20 million financing for MJar Holdings, LLC.
Represented Canaccord Genuity Corp. in connection with Aurora Cannabis Inc.’s (TSX: ACB) $115 million special warrant offering.
Represented a syndicate of underwriters, led by Canaccord Genuity Corp. and including GMP Securities L.P., PI Financial Corp., Eight Capital, Industrial Alliance Securities Inc., Beacon Securities and Mackie Research Capital Corporation, in connection with Aurora Cannabis Inc.’s (TSX: ACB) $75 million bought deal and concurrent private placement.
Represented a syndicate of agents, led by Canaccord Genuity Corp. and including Industrial Alliance Securities Inc., Mackie Research Capital Corp. and Sprott Capital Partners, in connection with Maricann Group Inc. (CSE: MARI) $31 million secured convertible debenture offering.